Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan

  • Authors:
    • Mohammad Y. Gharaibeh
    • Sajida Batayneh
    • Omar F. Khabour
    • Azhar Daoud
  • View Affiliations

  • Published online on: July 1, 2010     https://doi.org/10.3892/etm_00000108
  • Pages: 701-705
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Attention deficit hyperactivity disorder (ADHD) is one of the most common neuropsychiatric disorders in children. In this study, the association between 10-repeats in the DAT1 gene and the (GT)n repeat in the DBH gene and ADHD was examined in children from Jordan. In addition, the levels of dopamine-β-hydroxylase enzyme activity in the plasma of ADHD children were evaluated. Fifty children with ADHD and 50 age- and gender-matched control subjects were recruited. The results showed significant differences between the ADHD group and controls with respect to the plasma levels of dopamine-β-hydroxylase enzyme activity (25.4±2.3 vs. 84.7±5.0 µmol/min; p<0.01). Moreover, the 10-repeat DAT1 gene and (GT)n DBH gene polymorphisms were significantly associated with ADHD development (p<0.05). In conclusion, the DBH and DAT1 genes appear to play a role in the development of ADHD in the Jordanian population.

Introduction

Attention deficit hyperactivity disorder (ADHD) is one of the most common neuropsychiatric and behavioral childhood disorders (1), affecting approximately 12% of school-aged children, with a higher prevalence in boys than girls (2). The disorder is characterized by reduced attention and hyperactivity (35); ADHD children are disorganized and have trouble fulfilling plans and completing tasks (6). The symptoms have been attributed, mainly, to lower norepinephrine and dopamine activities. Research has indicated a malfunction in dopamine-β-hydroxylase (DBH), which is responsible for maintaining the balance between dopamine and norepinephrine concentrations (2,711).

Recent data suggest that various polymorphisms of the dopamine-related genes are related to ADHD. Studies involving children from the US, Czech Republic, Finland, Brazil and India demonstrated a correlation between DBH gene polymorphisms and increased susceptibility to ADHD (1,1014). Moreover, studies from the US, Taiwan, UK and China revealed strong associations between ADHD and polymorphisms of the dopamine transporter gene (DAT1) (12,15,16). Despite accumulating evidence, no studies have examined these relationships in Arab/Middle Eastern populations. Therefore, in this study the plasma levels of DBH enzyme activity were evaluated in ADHD children from Jordan. In addition, the association between polymorphisms of the DAT1 and DBH genes and ADHD was examined.

Materials and methods

Subjects

Fifty children with ADHD (2.5–14 years of age) were recruited from the King Abdullah University Hospital and the Princess Rahmah Teaching Hospital. The children were diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorder-IV (DSM-IV) criteria by a pediatric neurologist. Fifty healthy children, matched for age and gender, were included in the study as controls. The control children attended the same hospitals for reasons other than neuropsychiatric disorders. Written informed consent was obtained from the participants’ guardians according to the Jordan University of Science and Technology Institutional Review Board.

DNA extraction

DNA was extracted from EDTA blood samples obtained from the participants using the Wizard DNA Extraction kit (Promega, Madison, WI, USA) according to the manufacturer’s instructions. The concentration of the extracted DNA was measured using SmartSpect™3000 (Bio-Rad, Hertfordshire, UK). DNA samples were stored at −20°C until use.

Genotyping of the DAT1 polymorphism

The 40-bp variable number tandem repeat (VNTR) of the DAT1 3′-untranslated region was analyzed using polymerase chain reaction (PCR) as previously described (17). Detection of various repeats was performed using 12% polyacrylamide gel and proper DNA ladders.

Genotyping of the DBH polymorphism

The DBH dinucleotide repeat was performed using previously described primers and PCR conditions (18). The PCR products were digested with HaeIII at 37°C for 2 h. The digested PCR products were analyzed using 12% polyacrylamide gels, and the sizes of the dinucleotide repeat were measured using proper DNA ladders (19).

Determination of dopamine-β-hydroxylase activity

The activity of the DBH enzyme was measured using the patch adsorption method according to the protocol used by Nagatsu and Udenfriend (20). In brief, 50 μl of serum was added to 350 μl of distilled water, and the diluted serum was added to 600 μl of a reagent mixture [200 μl of sodium acetate buffer (1 mol/l, pH 5.0), 50 μl of sodium fumarate (0.2 mol/l), 50 μl of ascorbic acid (0.2 mol/l), 50 μl of catalase (1 mg/ml), 50 μl of tyramine (0.4 mol/l), 50 μl of pargyline (20 mmol/l) and 150 μl of N-ethylmalemide (0.2 mol/l)]. As a blank, 50 μl of serum was diluted to 400 μl by distilled water, boiled at 95°C for 5 min and then added to 600 μl of the reagent mixture described above. The reaction mixtures were incubated at 37°C for 60 min with continuous shaking. At the end of the incubation period, the reactions were stopped by adding 200 μl of trichloroacetic acid (3 molar), and the mixtures were centrifuged at 2,000 x g for 10 min. The supernatant was transferred to a new tube containing 200 μl of Dowex-50 (H+, 200–400 mesh), which was fully equilibrated with acetate buffer. The precipitants were then washed three times with distilled water coupled with centrifugation at 2,000 x g for 5 min each. After the last wash, 1 ml of NH4OH (4 molar) was added to elute the adsorbed amines. The mixtures were then centrifuged at 2,000 x g for 5 min, and the supernatants were transferred to new tubes. Following this, 100 μl of NaIO4 (200 g/l) was added to the tube to convert the octopamine in the supernatant to para-hydroxybenzaldehyde. Finally, 100 μl of Na2S2O5 (10 g/l) was added to reduce the excess periodate. Absorbance was then measured at 330 nm using microcuvets with a 1-cm light path. The activity of the enzyme was expressed in terms of μmol/min; the level of DBH enzyme.

Statistical analysis

Statistical evaluation of the results was carried out by comparing allele, genotype and predicted phenotype distributions using the χ2 test. If n<5, the Fisher’s exact test was used. The SPSS 15.0 statistical software package (SPSS Inc., Chicago, IL, USA) was used for all statistical evaluations. Comparisons that involved two groups were carried out using the Student’s t-test. A p-value of <0.05 was considered significant.

Results

The sample ratio of boys to girls was 4:1. The median age was 7.1±1.2 years for the ADHD subjects and 8±1.4 for the control group (p>0.05).

According to the distribution of the DAT1 polymorphism genotypes shown in Table I, 9/9 and 9/10 were most common in the controls (34 and 28%, respectively). However, the most common genotypes in the ADHD group were 9/10 and 10/10 repeats (34 and 32%, respectively). Additionally, Table II shows that the 9-repeat allele (58%) was common in the controls, while the 10-repeat allele was common in the ADHD group (50%, p<0.05).

Table I.

Distribution of the genotypes of the DAT1 polymorphism.

Table I.

Distribution of the genotypes of the DAT1 polymorphism.

GenotypePatients n (%)Control n (%)
6/61 (2)0 (0)
6/72 (4)0 (0)
7/73 (6)3 (6)
7/92 (4)10 (20)
7/100 (0)2 (4)
9/97 (14)17 (34)
9/1017 (34)14 (28)
9/111 (2)0 (0)
10/1016 (32)4 (8)
10/111 (2)0 (0)

[i] p<0.001, based on the Fisher’s exact test.

Table II.

Frequency of the DAT1 alleles.

Table II.

Frequency of the DAT1 alleles.

AllelesPatients (n)Controls (n)
DAT640
DAT71018
DAT93458
DAT105024
DAT1120

[i] p<0.05, based on the Fisher’s exact test.

As shown in Table III, the frequency of (GT)n DBH polymorphism A2/A3 and A4/A6 genotypes was higher in the ADHD children (58 and 40%, respectively), while the frequency of the A2/A4 genotype was higher in the controls (56%, p<0.05). In agreement with the genotype distribution, Table IV shows that the A3 and A6 allelic frequencies were higher in the ADHD group, while the frequency of the A4 allele was higher in the control group (p<0.001).

Table III.

Distribution of the genotypes of the (GT)n DBH polymorphism in the studied population.

Table III.

Distribution of the genotypes of the (GT)n DBH polymorphism in the studied population.

GenotypePatients n (%)Controls n (%)
A2/A329 (58)9 (18)
A2/A41 (2)28 (56)
A3/A40 (0)6 (12)
A3/A60 (0)1 (2)
A4/A620 (40)6 (12)

[i] p<0.05, based on the Fisher’s exact test.

Table VI.

Allelic frequencies of the (GT)n DBH polymorphism in the studied population.

Table VI.

Allelic frequencies of the (GT)n DBH polymorphism in the studied population.

GenotypePatients (n)Controls (n)
A23037
A32916
A42140
A6207

[i] p<0.001.

The result also revealed a significant decrease (p<0.01) in the plasma DBH activity in the ADHD (25.412±2.32 μmol/min) compared to the control (84.689±5.01 μmol/min) children (Table V). Moreover, the percentage of children with abnormally low activity was higher (p<0.01, Table V) in the ADHD vs. the control group.

Table V.

DBH enzyme activity in the blood levels of the study subjects.

Table V.

DBH enzyme activity in the blood levels of the study subjects.

Dopamine-β-hydroxylasePatients (n=50)Controls (n=50)P-value
Activity (mean μmol/min)25.0±2.384.6±5.0<0.01
Description of activity<0.01
  High (>50 μmol/min)443
  Low (<50 μmol/min)467

Discussion

The present study revealed that the frequency of the (GT)n repeat 5’ in the DBH gene was higher in the ADHD group among Jordanian children. In addition, a significantly lower level of DBH activity was detected in ADHD children compared to the controls.

Previous studies have revealed that an imbalance between the dopaminergic and noradrenergic systems is implicated in the development of ADHD in children (10,16,21). The two systems are connected by the activity of the DBH enzyme, which is expressed in the central and peripheral nervous systems and catalyzes the conversion of dopamine to norepinephrine (22). Genetic variations in the DBH gene suggest that a lower enzyme activity increases the susceptibility of developing ADHD in children. Several studies have shown an increased TaqI A polymorphism in children with ADHD (12,14,23). In addition, several single-nucleotide polymorphisms in the DBH gene have been implicated in ADHD etiology (21). Moreover, the DBH (GT)n repeat polymorphism was found to contribute to the development of ADHD in children from the US (23). In the the present study, the DBH (GT)n polymorphism was associated with ADHD children, supporting the hypothesis that DBH plays a key role in the ADHD trait. Thus, similar to other populations, genetic variations in the DBH gene may play a role in the development of ADHD in Jordanian children.

Another gene that plays a key role in regulating the dopaminergic system is DAT1, which codes for a dopamine transporter expressed in pre-synaptic neurons (24). Previous studies have implicated excess dopamine clearance in the synapses of ADHD as part of the etiology of the disease (25). In addition, positron emission tomography imaging indicated dysregulation of DAT1 in the striatum of subjects with ADHD (26,27). The present results indicate that VNTR in the 3′ untranslated region of DAT1 is associated with ADHD with a high frequency of the 10R allele in affected children. In agreement with this result, several studies (18,28) have found that homozygosity for the 10R allele of the DAT1 gene was significantly greater in ADHD children from the US, Ireland and Czech Republic (12,29,30). In addition, a meta-analysis found a significant association between the 10R allele and ADHD development (31,32). Thus, similar to other populations, VNTR in the 3′ untranslated region of DAT1 may play a role in the etiology of ADHD in children from Jordan.

In support of the genetic analysis, DBH enzyme activity was significantly different in the ADHD group compared to the controls. The plasma DBH level can be used as a marker to reflect sympathetic noradrenergic activity, since the enzyme is released into the blood stream during synaptic transmission (33). Although plasma DBH enzyme activity varies among unrelated individuals (18), it is generally accepted that children with ADHD have decreased plasma and urine DBH activities (10,19,34).

As is the case in most association studies, reported negative and positive associations with a given genetic variant are common. In the examined polymorphisms, lack of association between ADHD and the DBH (GT)n repeat was reported in Indians (35). Similarly, the absence of an association between ADHD and VNTR of the DAT1 3′-untranslated region was observed in studies from Brazil and Norway (1,17,23,3638). The discrepancy may be due to the complexity of ADHD, the differences in the genetic background of the studied populations, and the impact of environmental factors.

Previous studies have demonstrated that certain environmental factors, including maternal smoking or drinking habits during pregnancy, low birth weight, maternal age, stress and/or exposure to heavy metals such as zinc and mercury contribute to the development of ADHD (6,39). However, the contribution of environmental factors to the development of ADHD in Jordanian children was not examined in the present study; it will be investigated in future research.

Notably, DBH enzyme activity has been shown to change in individuals with certain diseases such as schizophrenia, Tourette syndrome, familial dysautonomia and orthostatic hypotension (40. Similarly, polymorphisms of DAT1 are associated with bipolar disorder, Parkinson disease and drug abuse (41,42). Therefore, future studies should examine common variants of the DBH and DAT1 genes in Jordanians.

Acknowledgements

The authors thank Dr Abdulla Al-Sharman for the help in recruiting participants and Mr. Essa S. Abdelhalim for the help with statistical analysis. The study was funded by grant no. 53/2008 to M.G. and O.K. from the Deanship of Scientific Research of the Jordan University of Science and Technology.

References

1. 

Cheuk DK and Wong V: Attention-deficit hyperactivity disorder and blood mercury level: a case-control study in Chinese children. Neuropediatrics. 37:234–240. 2006. View Article : Google Scholar : PubMed/NCBI

2. 

Sheehan K, Hawi Z, Gill M and Kent L: No association between TPH2 gene polymorphisms and ADHD in a UK sample. Neurosci Lett. 412:105–107. 2007. View Article : Google Scholar : PubMed/NCBI

3. 

Gornick MC, Addington A, Shaw P, et al: Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit/hyperactivity disorder (ADHD): an update. Am J Med Genet B Neuropsychiatr Genet. 144B:379–382. 2007. View Article : Google Scholar : PubMed/NCBI

4. 

Thapar A, O’Donovan M and Owen MJ: The genetics of attention deficit hyperactivity disorder. Hum Mol Genet. 14:R275–R282. 2005. View Article : Google Scholar : PubMed/NCBI

5. 

Tsai SJ: Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications. Med Hypotheses. 68:896–899. 2007. View Article : Google Scholar

6. 

Rowland AS, Lesesne CA and Abramowitz AJ: The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Ment Retard Dev Disabil Res Rev. 8:162–170. 2002. View Article : Google Scholar : PubMed/NCBI

7. 

Gizer IR, Ficks C and Waldman ID: Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 126:51–90. 2009. View Article : Google Scholar : PubMed/NCBI

8. 

Guan L, Wang B, Chen Y, et al: A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol Psychiatry. 14:546–554. 2009. View Article : Google Scholar

9. 

Hesse S, Ballaschke O, Barthel H and Sabri O: Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder. Psychiatry Res. 171:120–128. 2009. View Article : Google Scholar : PubMed/NCBI

10. 

Kopeckova M, Paclt I, Petrasek J, Pacltova D, Malikova M and Zagatova V: Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6–10 age. Neuro Endocrinol Lett. 29:246–251. 2008.PubMed/NCBI

11. 

Nyman ES, Ogdie MN, Loukola A, et al: ADHD candidate gene study in a population-based birth cohort: association with DBH and DRD2. J Am Acad Child Adolesc Psychiatry. 46:1614–1621. 2007. View Article : Google Scholar : PubMed/NCBI

12. 

Barkley RA, Smith KM, Fischer M and Navia B: An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet. 141B:487–498. 2006.PubMed/NCBI

13. 

Kopeckova M, Paclt I and Goetz P: Polymorphisms and low plasma activity of dopamine-beta-hydroxylase in ADHD children. Neuro Endocrinol Lett. 27:748–754. 2006.PubMed/NCBI

14. 

Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA and Hutz MH: Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet. 114:154–158. 2002. View Article : Google Scholar : PubMed/NCBI

15. 

Brookes KJ, Mill J, Guindalini C, et al: A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry. 63:74–81. 2006. View Article : Google Scholar

16. 

Krause J: SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother. 8:611–625. 2008. View Article : Google Scholar : PubMed/NCBI

17. 

Qian Q, Wang Y, Zhou R, Yang L and Faraone SV: Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder. Am J Med Genet B Neuropsychiatr Genet. 128B:84–89. 2004. View Article : Google Scholar

18. 

Wei J, Xu HM, Ramchand CN and Hemmings GP: Is the polymorphic microsatellite repeat of the dopamine beta-hydroxylase gene associated with biochemical variability of the catecholamine pathway in schizophrenia? Biol Psychiatry. 41:762–767. 1997. View Article : Google Scholar : PubMed/NCBI

19. 

Galvin M, Ten Eyck R, Shekhar A, et al: Serum dopamine beta hydroxylase and maltreatment in psychiatrically hospitalized boys. Child Abuse Negl. 19:821–832. 1995. View Article : Google Scholar : PubMed/NCBI

20. 

Nagatsu T and Udenfriend S: Photometric assay of dopamine – hydroxylase activity in human blood. Clin Chem. 18:980–983. 1972.

21. 

Kopeckova M, Paclt I and Goetz P: Polymorphisms of dopamine-beta-hydroxylase in ADHD children. Folia Biol. 52:194–201. 2006.PubMed/NCBI

22. 

Hartman BK: Immunofluorescence of dopamine-hydroxylase. Application of improved methodology to the localization of the peripheral and central noradrenergic nervous system. J Histochem Cytochem. 21:312–332. 1973. View Article : Google Scholar : PubMed/NCBI

23. 

Smith KM, Daly M, Fischer M, et al: Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am J Med Genet B Neuropsychiatr Genet. 119B:77–85. 2003. View Article : Google Scholar : PubMed/NCBI

24. 

Parsian A and Zhang ZH: Human dopamine transporter gene polymorphism (VNTR) and alcoholism. Am J Med Genet. 74:480–482. 1997. View Article : Google Scholar : PubMed/NCBI

25. 

Prince J: Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update. J Clin Psychopharmacol. 28:S39–S45. 2008. View Article : Google Scholar : PubMed/NCBI

26. 

Jucaite A, Fernell E, Halldin C, Forssberg H and Farde L: Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry. 57:229–238. 2005. View Article : Google Scholar

27. 

Spencer TJ, Biederman J, Madras BK, et al: Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry. 62:1059–1061. 2007. View Article : Google Scholar : PubMed/NCBI

28. 

Cook EH Jr, Stein MA, Krasowski MD, et al: Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 56:993–998. 1995.PubMed/NCBI

29. 

Drtilkova I, Sery O, Theiner P, et al: Clinical and molecular-genetic markers of ADHD in children. Neuro Endocrinol Lett. 29:320–327. 2008.PubMed/NCBI

30. 

Hawi Z, Segurado R, Conroy J, et al: Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder. Am J Hum Genet. 77:958–965. 2005. View Article : Google Scholar : PubMed/NCBI

31. 

Faraone SV and Khan SA: Candidate gene studies of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 67(Suppl 8): 13–20. 2006.

32. 

Yang XM, Wang SH, Yang YD, et al: A dopaminergic projection from the dorsal raphe nucleus to the inner ear. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 41:857–860. 2006.PubMed/NCBI

33. 

O’Connor DT, Levine GL and Frigon RP: Homologous radio-immunoassay of human plasma dopamine-beta-hydroxylase: analysis of homospecific activity, circulating plasma pool and intergroup differences based on race, blood pressure and cardiac function. J Hypertens. 1:227–233. 1983.

34. 

Galvin MR, Stilwell BM, Shekhar A, Kopta SM and Goldfarb SM: Maltreatment, conscience functioning and dopamine beta hydroxylase in emotionally disturbed boys. Child Abuse Negl. 21:83–92. 1997. View Article : Google Scholar : PubMed/NCBI

35. 

Bhaduri N, Sarkar K, Sinha S, Chattopadhyay A and Mukhopadhyay K: Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India. Cell Mol Neurobiol. 30:265–274. 2010. View Article : Google Scholar : PubMed/NCBI

36. 

Genro JP, Polanczyk GV, Zeni C, et al: A common haplotype at the dopamine transporter gene 5’ region is associated with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 147B:1568–1575. 2008.

37. 

Johansson S, Halleland H, Halmoy A, et al: Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs. Am J Med Genet B Neuropsychiatr Genet. 147B:1470–1475. 2008. View Article : Google Scholar : PubMed/NCBI

38. 

Langley K, Turic D, Peirce TR, et al: No support for association between the dopamine transporter (DAT1) gene and ADHD. Am J Med Genet B Neuropsychiatr Genet. 139B:7–10. 2005. View Article : Google Scholar : PubMed/NCBI

39. 

Swanson JM, Kinsbourne M, Nigg J, et al: Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev. 17:39–59. 2007. View Article : Google Scholar

40. 

Yoon DY, Rippel CA, Kobets AJ, et al: Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3). Am J Med Genet B Neuropsychiatr Genet. 144B:605–610. 2007. View Article : Google Scholar : PubMed/NCBI

41. 

Bannon MJ: The dopamine transporter: role in neurotoxicity and human disease. Toxicol Appl Pharmacol. 204:355–360. 2005. View Article : Google Scholar : PubMed/NCBI

42. 

Kurian MA, Zhen J, Cheng SY, et al: Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest. 119:1595–1603. 2009.PubMed/NCBI

Related Articles

Journal Cover

July-August 2010
Volume 1 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gharaibeh MY, Batayneh S, Khabour OF and Daoud A: Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan . Exp Ther Med 1: 701-705, 2010.
APA
Gharaibeh, M.Y., Batayneh, S., Khabour, O.F., & Daoud, A. (2010). Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan . Experimental and Therapeutic Medicine, 1, 701-705. https://doi.org/10.3892/etm_00000108
MLA
Gharaibeh, M. Y., Batayneh, S., Khabour, O. F., Daoud, A."Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan ". Experimental and Therapeutic Medicine 1.4 (2010): 701-705.
Chicago
Gharaibeh, M. Y., Batayneh, S., Khabour, O. F., Daoud, A."Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan ". Experimental and Therapeutic Medicine 1, no. 4 (2010): 701-705. https://doi.org/10.3892/etm_00000108